Insiders AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 05:57:22 15/05/26 pm AEST			5-day change	1st Jan Change
13,860.00 ^GBX	+0.87%		+3.64%	+0.29%

15/05	AstraZeneca bladder cancer trial yields encouraging results	AN
15/05	European Equities Traded in the US as American Depositary Receipts Tracking Higher in Thursday Trading	MT

Insiders

23/04	Astrazeneca plc Announces Stepping Down of Rene Haas as Non-Executive Director, Effective April 30, 2026	CI
24/02	AstraZeneca PLC Announces Directorate And Committee Changes, Effective April 9, 2026	CI
24/02	AstraZeneca announces retirement of non-executive director Nazneen Rahman	RE
12/02	China charges former AstraZeneca regional head Leon Wang	RE
14/01	AstraZeneca CFO on M&A Strategy and Obesity Market	MT
09/01	AstraZeneca Appoints Rick R. Suarez As Senior Vice President, US President, And Head Of US BioPharmaceuticals Business Unit	CI
09/01	Astrazeneca Names Rick Suarez Head of US BioPharmaceuticals Unit	MT
08/01	AstraZeneca names insider Rick Suarez as head of US biopharmaceuticals unit	RE
08/01	AstraZeneca names Rick Suarez head of US biopharmaceuticals unit	RE
08/01	AstraZeneca plc Announces Executive Changes , Effective March 1, 2026	CI
22/12	Jacobio Strikes New Cancer Drug Deal with AstraZeneca	MT
02/12	Faron appoints former AstraZeneca Netherlands finance chief as CFO	AN
17/11	Hims & Hers names ex-FDA official Deb Autor as first policy chief	RE
07/11	AstraZeneca Profit Beats Estimates on Cancer, Diabetes Drugs	MT
07/10/25	PRESS DIGEST- Financial Times - October 7	RE
30/07/25	US Expansion Not Driven By Tariffs: AstraZeneca CFO	MT
30/07/25	AstraZeneca Profit, Revenue Lifted by Cancer Drugs	MT
23/07/25	PRESS DIGEST-New York Times business news - July 23	RE
02/07/25	PRESS DIGEST-British Business - July 2	RE
21/05/25	AstraZeneca chief executive joins Agilent Technologies board	AN
30/04/25	PRESS DIGEST-British Business - April 30	RE
29/04/25	AstraZeneca Gets Profit Boost From Diabetes, Cancer Drugs	MT
12/04/25	AstraZeneca PLC Appoints Karen Knudsen as Director	CI
21/03/25	AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals	RE
21/03/25	AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals	RE